-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HIOpEaFPk8MDsNg5yh6qHDMN9xn+7Rsy8qTWPPeforU0083bMJHiQTrMdDpKqjlX yTFh6EJ6Cs/3HBry5fYbfA== 0000950144-05-007981.txt : 20050801 0000950144-05-007981.hdr.sgml : 20050801 20050801152403 ACCESSION NUMBER: 0000950144-05-007981 CONFORMED SUBMISSION TYPE: 425 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20050801 DATE AS OF CHANGE: 20050801 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IVAX CORP CENTRAL INDEX KEY: 0000772197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161003559 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 425 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09623 FILM NUMBER: 05988125 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3055756000 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: IVAX CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IVACO INDUSTRIES INC DATE OF NAME CHANGE: 19871213 FORMER COMPANY: FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC DATE OF NAME CHANGE: 19870611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: IVAX CORP CENTRAL INDEX KEY: 0000772197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161003559 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 425 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3055756000 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: IVAX CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IVACO INDUSTRIES INC DATE OF NAME CHANGE: 19871213 FORMER COMPANY: FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC DATE OF NAME CHANGE: 19870611 425 1 g96548e425.htm IVAX CORPORATION IVAX Corporation
 

    Filed by: IVAX Corporation
Pursuant to Rule 425 under the
Securities Act of 1933 and deemed filed
pursuant to Rule 14a-12 under the
Securities Exchange Act of 1934
 
Subject Companies: Ivax Corporation
Commission File No. 001-09623

(IVAX LOGO)   IVAX Corporation
4400 Biscayne Boulevard
Miami, FL 33137
Telephone: 305-575-6000
Announcement to Employees
Today, we announced the merger of IVAX Corporation and Teva Pharmaceutical Industries, Limited. As most of you are aware, Teva is a global pharmaceutical company that specializes in the development, manufacture and marketing of generic and proprietary pharmaceuticals and active pharmaceutical ingredients. Together, IVAX and Teva will form the largest generic pharmaceutical company in the United States and, in terms of prescriptions, the second largest company among all brand and generic companies in the U.S. We expect the combination of these two strong companies will not only create shareholder value, but will also produce a formidable, global pharmaceutical company.
It will take a significant period of time, perhaps a year or more, to complete this transaction and integrate our operations. Prior to the closing, IVAX will continue operating as an independent company and, as always, we are dependent on the continued dedication of our valued employees. We will be working closely with Teva’s during this period to develop an integration plan and will be informing you about these plans with periodic communications as these plans become available.
We want to express our sincere appreciation to all our dedicated employees for the continued excellence of their effort and performance in creating a valued and highly-respected company.
(FROST SIG)
Phillip Frost, M.D.
Chairman and Chief Executive Officer

GRAPHIC 2 g96548g965481eo1.gif GRAPHIC begin 644 g96548g965481eo1.gif M1TE&.#=AD0!``/<``````(````"``("`````@(``@`"`@,#`P,#/($.*'$FRI,F3*%->M,>RI4N7 M`E_*;(EPIDU[!6_>5"CSGTV>.FE*#"J4*,N:1H\23`HS8<^?3HU*O"<%@-6K M6*V2$E@UJ][A7/H/0=>W5I-(F6N0%%ZL M6R-N^GLUL%O"".C:(WPU+,%[C+VB/6CO+F*?:2,#<`SQ\-_)GM\FX3OP0.2] M!2UK#GS0=.3)2T._W4J:X>+(CF5_K?W/+V/.`A%HSLKZH&ZOQ05"9HPZHFO& MB?\=QRKEH&JRS0?Z'FYUDT&EU['G_PR?50I:W@N?_TTRM)J\<+.R)^O/8)Y)Y6!BWW5W4Q<45??0KMAQ=?:C&V"7H-#<88;`,"T)^" MA,&'F7`+6H4@0B!"-Y"%A`$7$7E912?=A?.E6)"!V!U(H4\L8N68@V311E&& MH[7W6VJ,C49:CC3NIE"2;TV&(G\6W=8A01FZZ%-DR4F)'8]EW5@7ECX-R)Y% M7&;57V3Z%5G;DY*5^):7_[!)UH3_D;6A1'62965D!>5I9HQOEFD5G(**R*17 M$UZ4XU5\:2D:D835-A9>U14*YS]%+BJ%E1#-Y>A;(PK$W%*,!3B0FSW^J7@48K6W4`@!61I^^!5RZ67DXZ5^NTACMW+GEZQ5: MG#V/&WB7G*Z/P\`;P=T?/E*'4M[9?*4\JW]V,VKO7:&XD,D MN.+4N[Z4],^[B-/C>\,*_$-B;T]9N6[3W/GTM)1F_8-^6B.;PLR&MQ"![6?E MLA("X5,XB[AL>,1;T(8D%T'G#4E58*H(`K/U/VI9Z7W:!KH3TL5+L$K+"S8SP3BZ3G4-<=B,K&NPQ1R31 M:IB'L]%%1'WKX6<O[H-.N$$")>Q*#. MZ+,U-CKL?.V3VX'NZ++7B:XMRMN=6\SCMPQ-;3['\8QNS"))Y8AI4[.*B50Z M]1*?"&4ILXP;9IA"$Z7$;2:R5.`=T>5$84[D4EXRIDJ6R:8VM\G-;GKSF^`,)T,"`@`[ ` end GRAPHIC 3 g96548g965481eo2.gif GRAPHIC begin 644 g96548g965481eo2.gif M1TE&.#=AQ`!F`/<``````(````"``("`````@(``@`"`@,#`P,#%M&N-FT$+O*<:(:G+KW-+W(R0=F7=P"-N%GTP]<(MK8,K7QA886.$ MEI=+/\B8./2%]YX[SCZ=(6^%:!>3:2R6Q-2`")7H'(B9,?634!Z:A!B- MM@'Y#V'!Z=C3%N\)N5%1(U*W&H.Z&7G2`9>A5=1+-1G8D&\(J:C1/5HJ%>-( M:*E4DU!IA90:8R+>EA%>$!4%)'\^)!)@B9F96F"IE?D@13-"I&!! M'&J$&``4-C@F5='9=!*C$0T*EZ5#1A=1429*)266BCVZT5.;`BB??9.IU"AX M0=TITZ0I@2E=!``<;FZJXN>BMI1K0*Y21)BMBJ$8D&%$F1/ M8DE@ZEU-OL;$6'J7)1%F1XG2B*+16E%P'*5><6#6II2>\U!7.S6$K%V M,]'9LTX2$^%"9C@N!($V,#0D1YG[P]9"-[E"IGK M%+N;;R1W8T$-""=JG4('(K$1:[M;X@.U%+>^#+8$%*])YD/8MLB.+/35#CL:P\174=`]-JY"6?UCPJ78]2 M'$;@!Y'W*.LI69%-TZR3$NT@1C0@,XVE_WXW-.Z4CB:W04!*6B>0ROT#,?0: MDPWS)#C&K<^*`]0@B]#2+`$^ATE6.TA@O"00Y7TH(ZRI3&>8Y*8Q8:AY&;/B M06@G$?4=;'#%\E!.U$(O\MEQ*71:2GO4`X`PI:YU-+/(TFRC%=:H)8DQ(E(# M!;<1$`[F445YD.*X.)"5B$9Q0>G,(CDG2-<][W3%8PA\SC4DVK`H3]BC9$:6 M&)%GT6@S*IS)([V&FY!8!R_4`@T"[).E?_#KB?QAXNXP8D2%`#,QG4'2)(LE M%&JM;R;HHX[.J(,>/NFG3*_K#7\HI)5,#N1!ENQ2-L4BO%$:;H`(")22_"7# MB$AP?"R,EI!&B#Z1Q+PG:;.AS!]7Q$2'/$N1X314`14IMX,Q*)YI0>67"@@: M#\&Q7MML""DRFCREW*\A@4R5OY`",%LR9)D8H?]@7])HJ&]9):+G40SP;B7' M@F"M/!YK&J](45"9*"8V/_L>P4ASP*P)%2FA$MY14^2:I0KD635UB4@&VANG M>F>=96FF=U2J%)%L+)87L6I;0G(6KBHE,#;AYQP=UZZ&UL6=<\RBYM*R&0HF M\B*DD.A;2=?!MP32<-SLJ4.TFB/2Y4]IG>L71]_"I;UAU2<<1-1CA9,;POKN MKV.-$4M)DE?=2`N,=2%C)TMRTZ9*J%EO>9<82S+2W'2+-9/=47LF_C#T@D(`#L_ ` end -----END PRIVACY-ENHANCED MESSAGE-----